851-P: Sleep and Quality of Life in Adolescents with Type 1 or Type 2 Diabetes

Abstract

Poor sleep due to the influence of mobile technology and hectic schedules is common in adolescents and may affect overall diabetes management. The purpose of this study was to examine associations between sleep quality and perceptions of physical health, emotional well-being, self, family support, friendships and life satisfaction in adolescents with diabetes. Seventy-six adolescents with either T1D (n = 49; 25 males) or T2D (n= 27) completed a self-report global measure of sleep quality using a 5-point scale with higher values representing more sleep difficulty and measures of quality of life based upon subscales from well-validated and reliable instruments. These included the Kiddo KINDL® and the Diabetes Quality of Life Instrument for Youth with higher values on a 5-point scale indicating more positive perceptions of quality of life and life satisfaction. Hemoglobin A1c% (HbA1c) was obtained using the Abbott IMx® assay method. Adolescents with T2D were significantly older (15.2±2.0 vs. 14.0±1.4 years), had higher body mass index z-scores (2.0±0.6 vs. 0.6±0.9) and less duration of diabetes (2.0±1.8 vs. 5.5±3.2 years) (P < 0.01). There were no group differences in median scores for sleep quality or mean HbA1c (8.1±2.4 vs. 8.8±1.8) and no association between HbA1c and sleep quality. Using Spearman rho correlational analyses, there were significant associations between sleep quality and perceptions of physical health (rho = -.44), self (rho = -.19), family (rho = -.20), friends (rho = -.23) and life satisfaction (rho = -.25), P <0.05). Significant associations were stronger in those with T1D, ranging from rho = -.36 to -.64, including emotional well-being, likely due to the larger sample size for those with T1D. Results indicate those with greater sleep difficulty had lower quality of life. Greater emphasis on overall sleep quality and personal health and relationships are needed in future research and the clinical management of diabetes in adolescents. Disclosure M.S. Faulkner: None. Funding National Institutes of Health (R01NR07719)